Elon Musk, the CEO of Tesla and SpaceX, recently revealed his significant weight loss, attributing it to the use of GLP-1 medications. He showcased his slimmer physique in a Christmas-themed photo on X (formerly Twitter), sparking a conversation about the effectiveness and side effects of different weight loss drugs.
Musk’s initial post featured him in a Santa suit, highlighting his noticeably reduced belly. He humorously captioned the image “Ozempic Santa,” referencing the popular GLP-1 medication often prescribed for weight loss. In subsequent posts, he clarified that he actually used Mounjaro (tirzepatide), another GLP-1 drug, explaining that it “doesn’t have the same ring to it” as Ozempic.
This revelation led to a flurry of questions from users about the differences between Ozempic and Mounjaro. Musk responded by stating that he had tried both medications and found Mounjaro to be more effective and with fewer side effects. He candidly described experiencing excessive gas and burping while taking high doses of Ozempic, comparing himself to Barney Gumble from The Simpsons. Mounjaro, he claimed, offered a better experience with improved results.
:max_bytes(150000):strip_icc():focal(776×240:778×242)/elon-musk-tesla-cybertruck-041924-1-9641f8695bed496ea5b4212836d9c69f.jpg)
Musk’s weight loss journey isn’t solely reliant on medication. He has previously mentioned incorporating intermittent fasting into his routine and acknowledged his aversion to exercise. In 2022, he disclosed using Wegovy, another weight loss drug in the GLP-1 class. This recent revelation about Mounjaro adds another chapter to his ongoing efforts to manage his weight.
Musk has been a vocal advocate for making GLP-1 drugs more accessible and affordable, believing they hold significant potential for improving public health and longevity. He has stated that widespread access to these medications could dramatically enhance the well-being of Americans.
However, his stance isn’t without its critics. Some, like Robert F. Kennedy Jr., argue that lifestyle changes, such as adopting a healthy diet and preventing obesity, should be prioritized over pharmaceutical interventions. While acknowledging the potential benefits of GLP-1 drugs, they emphasize the importance of addressing the root causes of weight gain through non-pharmaceutical means. They suggest that medication should be considered as a secondary option after lifestyle modifications have been implemented.
:max_bytes(150000):strip_icc():focal(776×240:778×242)/elon-musk-tesla-cybertruck-041924-1-9641f8695bed496ea5b4212836d9c69f.jpg)
Elon Musk’s public discussion of his weight loss journey and his use of GLP-1 medications has ignited a broader conversation about the role of pharmaceuticals in weight management, sparking debate about the balance between lifestyle changes and medical interventions in achieving a healthy weight.
